Explore
Watchlists
Share
EQHQ
Beta
Login
EQHQ
Beta
Search your stocks
Ctrl+K
Login
Command Palette
Search for a command to run...
BETA
Overview
News Feed
Financials
Ratios
Peers
Shareholding
Concall
Documents
BETA
Beta Drugs Ltd.
1720
(-0.64%)
1W:
-4.88%
1M:
-6.94%
1Y:
+25.98%
Add
Beta Drugs Quarterly Results
Share
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Pros & Cons
POSITIVES
Consistent revenue growth observed over the last four quarters, indicating strong demand for products.
Improved profit margins in the latest quarter, suggesting better cost management and pricing strategies.
Strong cash flow generation, which enhances financial stability and supports future investments.
NEGATIVES
Declining net profit in the last quarter compared to previous quarters, raising concerns about profitability sustainability.
Increased operational costs reported, which could impact margins if not controlled effectively.
Inventory levels have risen significantly, indicating potential overproduction or reduced sales efficiency.
Quarterly Results Data
(Numbers are in Crore)
Field
Trend
Expenses
-
Operating Profit
-
Other Income
-
Tax
-
Menu
Explore
Watchlists